An update of antispike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies

The use of monoclonal antibodies has expanded beyond the realm of autoimmune disease and cancer therapeutics to communicable diseases. Their antiviral activities were evaluated in some diseases such as SARS MERS (Middle East Respiratory Syndrome) and Ebola. In recent times, antispike SARS-CoV-2 mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Suparna, Choudhury, Shouvik, Das, Debaleena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012417/
https://www.ncbi.nlm.nih.gov/pubmed/35343208
http://dx.doi.org/10.4103/ijp.ijp_519_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012417/
https://www.ncbi.nlm.nih.gov/pubmed/35343208
http://dx.doi.org/10.4103/ijp.ijp_519_21

Ejemplares similares